Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Clinuvel Pharmaceuticals Reports Positive Cash Flow of $2.49m for the March 2019 Quarter

14 May 2019  |  19:43:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Appendix 4C - quarterly

Clinuvel Pharmaceuticals reported positive cash flow of $2.49m for quarter ended 31 March 2019. Operating cash flow for the period was $2.52m. Investing cash flow was $(27,000). Financing cash flow was nil. Cash in hand at the end of the quarter was $44.98m.

Consolidated Statement of Cash Flow for the Quarter ended 31 March 2019

Current Quarter $A'000- 31 March 2019 Year to Date $A'000-9 Months
Net Operating Cash Flows 2,516 9,764
Net Investing Cash Flows (27) (215)
Total Operating and Investing Cash Flows 2,489 9,549
Net Financing Cash Flows 0 (957)
Net Increase (Decrease) in Cash Held 2,489 8,592
Cash at Beginning of Quarter/Year to Date 42,827 36,198
Cash at End of Quarter 44,975 44,975
Please click here for full details

See more ASX300 News Announcements